The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophore for erythema.
11 November 1998
The location of DNA photodamage within the epidermis is crucial as basal layer cells are the most likely to have carcinogenic potential. We have determined the action spectra for DNA photodamage in different human epidermal layersin situ. Previously unexposed buttock skin was irradiated with 0.5, 1, 2, and 3 minimal erythema doses of monochromatic UVR at 280, 290, 300, 310, 320, 340, and 360 nm. Punch biopsies were taken immediately after exposure and paraffin sections were prepared for immunoperoxidase staining with a monoclonal antibody against thymine dimers that were quantitated by image analysis. Dimers were measured at two basal layer regions, the mid and the upper living epidermis.
The slopes of dose–response curves were used to generate four action spectra, all of which had maxima at 300 nm. Dimer action spectra between 300 and 360 nm were independent of epidermal layer, indicating comparable epidermal transmission at these wavelengths. Furthermore, we observed 300 nm-induced dimers in dermal nuclei; however, there was a marked effect of epidermal layer between 280 and 300 nm, showing relatively poor transmission of 280 and 290 nm to the basal layer.
These data indicate that solar UVB (≈295–320 nm) is more damaging to basal cells than predicted from transmission data obtained from human epidermisex vivo. The epidermal dimer action spectra were compared with erythema action spectra determined from the same volunteers and ultraviolet radiation sources. Overall, these spectral comparisons suggest that DNA is a major chromophore for erythema in the 280–340 nm region.
Young, A.R., Harrison, G.I., Chadwick, C.A., Nikaido, O., Ramsden, J. and Potten, C.S., 1998. The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophore for erythema. Journal of investigative dermatology, 111(6), pp.982-988.
Redirect to full article: Click Here
Categories: Medical & Pharmaceutical